MYC and cancer: These animal models included two cancer models characterized by an inflammatory environment, namely the transgenic over-expression of the Lymphotoxin (AlbLTα/β) and the c-myc transgenic mice (Tet-O-Myc) models, both resulting in inflammation-driven liver cancer.